RAVELLI, Cosetta
 Distribuzione geografica
Continente #
NA - Nord America 4.236
EU - Europa 3.169
AS - Asia 2.579
SA - Sud America 435
AF - Africa 63
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.501
Nazione #
US - Stati Uniti d'America 4.141
PL - Polonia 1.224
SG - Singapore 883
CN - Cina 782
IT - Italia 600
BR - Brasile 350
HK - Hong Kong 281
UA - Ucraina 269
DE - Germania 254
VN - Vietnam 217
FI - Finlandia 177
GB - Regno Unito 147
FR - Francia 135
IN - India 99
TR - Turchia 77
RU - Federazione Russa 73
IE - Irlanda 64
CA - Canada 51
BD - Bangladesh 39
NL - Olanda 39
ID - Indonesia 38
AR - Argentina 37
BE - Belgio 34
ES - Italia 34
JP - Giappone 29
ZA - Sudafrica 29
SE - Svezia 28
CZ - Repubblica Ceca 24
MX - Messico 24
IQ - Iraq 21
AT - Austria 17
EC - Ecuador 16
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
AU - Australia 10
MY - Malesia 10
VE - Venezuela 9
NG - Nigeria 8
PH - Filippine 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CO - Colombia 7
EG - Egitto 7
GR - Grecia 7
KR - Corea 7
CH - Svizzera 6
CL - Cile 6
EE - Estonia 6
KE - Kenya 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
AL - Albania 5
HN - Honduras 5
IR - Iran 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
MA - Marocco 4
OM - Oman 4
PE - Perù 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
GT - Guatemala 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 10.497
Città #
Warsaw 1.218
Ashburn 475
Singapore 468
Fairfield 310
Hong Kong 277
Brescia 263
San Jose 251
Jacksonville 211
Woodbridge 192
Ann Arbor 190
Chandler 180
Beijing 163
Seattle 136
The Dalles 134
Houston 125
Wilmington 123
Princeton 114
Cambridge 111
Los Angeles 109
New York 107
Helsinki 103
Dearborn 100
Council Bluffs 86
Dallas 86
Milan 76
Munich 72
Dong Ket 63
Nanjing 63
Istanbul 62
Lauterbourg 60
Dublin 59
Ho Chi Minh City 55
Shanghai 39
Buffalo 37
São Paulo 37
Turku 35
Jakarta 33
Orem 33
San Francisco 33
Brussels 31
Hanoi 31
Shenyang 31
London 28
Santa Clara 28
Changsha 26
Nanchang 26
Chicago 25
Moscow 25
Des Moines 24
Jinan 23
Madrid 23
San Diego 22
Atlanta 20
Guangzhou 20
Denver 19
Hebei 19
Phoenix 19
Tokyo 19
Chennai 18
Johannesburg 18
Nuremberg 18
Boston 17
Rome 17
Amsterdam 16
Brooklyn 16
Lappeenranta 16
Montreal 16
Frankfurt am Main 15
Toronto 15
Olomouc 14
Redondo Beach 14
Stockholm 14
Boardman 13
Tianjin 13
Haikou 12
Hangzhou 11
Augusta 10
Brasília 10
Fara Gera d'Adda 10
Zhengzhou 10
Dhaka 9
Kunming 9
Lanzhou 9
Poplar 9
Washington 9
Charlotte 8
Hefei 8
Jiaxing 8
Manchester 8
Mexico City 8
Paris 8
Romola 8
Abuja 7
Baghdad 7
Belo Horizonte 7
Coimbatore 7
Curitiba 7
Naples 7
Padua 7
Rio de Janeiro 7
Totale 7.218
Nome #
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 309
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 302
Claudin3 is localized outside the tight junctions in human carcinomas 290
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 287
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 282
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 272
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 271
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 267
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 264
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 238
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 224
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 217
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 198
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 196
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 191
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 187
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 185
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 184
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 181
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 173
Insights on the receptor dynamics during the spreading of endothelial cells 160
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 160
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 156
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 155
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 151
Simulation of VEGF receptor recruitment on ECs membrane 145
Vascular disrupting activity of combretastatin analogues 144
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 141
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 138
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 135
Role of VEGFs in metabolic disorders 134
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 134
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 133
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 129
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 127
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 123
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 122
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 122
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 118
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 117
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 116
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 115
Modeling cell motility and receptor dynamics 113
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 111
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 106
Role of gremlin-1 in the pathophysiology of the adipose tissues 104
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 103
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 103
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 103
VEGFR2 recruitment and activation by substratum-immobilized gremlin 102
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 101
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 100
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 100
Mechanobiology of the relocation of proteins in advecting cells: in vitro experiments, multi-physics modeling, and simulations 97
VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN 97
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 97
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants 95
Alternative method to visualize receptor dynamics in cell membranes 94
VEGFR2 recruitment and activation by substrate-immobilized VEGF 89
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 89
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 86
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 85
The contribution of obesogenic behavior on global warming 85
The D647N mutation of FGFR1 induces ligand-independent receptor activation 84
Deficiency of AP1 Complex Ap1g1 in Zebrafish Model Led to Perturbation of Neurodevelopment, Female and Male Fertility; New Insight to Understand Adaptinopathies 83
FGF-trapping hampers cancer stem-like cells in uveal melanoma 83
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 82
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 76
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 76
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 76
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 72
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 69
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 69
Two-Photon Microscopy for the Investigation of Morphological and Quantitative Changes in Skin Chrono- and Photo-Aging 56
The impact of adipokines on vascular networks in adipose tissue 45
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in In Vitro and In Vivo Models 29
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 16
The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination 4
Totale 10.673
Categoria #
all - tutte 42.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 0 0 0 0 95 107 93
2021/2022531 30 72 9 10 23 42 33 38 41 77 35 121
2022/2023555 82 45 27 29 50 111 13 58 76 9 23 32
2023/2024769 44 33 70 65 56 104 28 63 127 47 19 113
2024/20251.740 46 13 30 266 172 118 153 85 210 112 322 213
2025/20263.227 338 364 241 484 376 243 567 140 216 258 0 0
Totale 10.673